Advertisement

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity

Zachariah DeFilipp, Jonathan U. Peled, Shuli Li, Jasmin Mahabamunuge, Zeina Dagher, Ann E. Slingerland, Candice Del Rio, Betsy Valles, Maria E. Kempner, Melissa Smith, Jami Brown, Bimalangshu R. Dey, Areej El-Jawahri, Steven L. McAfee, Thomas R. Spitzer, Karen K. Ballen, Anthony D. Sung, Tara E. Dalton, Julia A. Messina, Katja Dettmer, Gerhard Liebisch, Peter Oefner, Ying Taur, Eric G. Pamer, Ernst Holler, Michael K. Mansour, Marcel R. M. van den Brink, Elizabeth Hohmann, Robert R. Jenq and Yi-Bin Chen

Article Information

Citation 
vol. 2 no. 7 745-753
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted February 20, 2018
  • Accepted February 27, 2018
  • Published online March 28, 2018.


Contributors 
  • Zachariah DeFilipp, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Jonathan U. Peled, 2Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;3Department of Medicine, Weill Cornell Medical College, New York, NY;
  • Shuli Li, 4Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;
  • Jasmin Mahabamunuge, 5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA;
  • Zeina Dagher, 5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA;
  • Ann E. Slingerland, 2Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;3Department of Medicine, Weill Cornell Medical College, New York, NY;
  • Candice Del Rio, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Betsy Valles, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Maria E. Kempner, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Melissa Smith, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Jami Brown, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Bimalangshu R. Dey, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Areej El-Jawahri, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Steven L. McAfee, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Thomas R. Spitzer, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;
  • Karen K. Ballen, 6Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA;
  • Anthony D. Sung, 7Division of Hematologic Malignancies and Cellular Therapies and
  • Tara E. Dalton, 7Division of Hematologic Malignancies and Cellular Therapies and
  • Julia A. Messina, 8Division of Infectious Diseases, Duke University School of Medicine, Durham, NC;
  • Katja Dettmer, 9Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;
  • Gerhard Liebisch, 10Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany;
  • Peter Oefner, 9Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;
  • Ying Taur, 3Department of Medicine, Weill Cornell Medical College, New York, NY;11Infectious Disease Service and Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Eric G. Pamer, 3Department of Medicine, Weill Cornell Medical College, New York, NY;11Infectious Disease Service and Center for Microbes, Inflammation and Cancer, Memorial Sloan Kettering Cancer Center, New York, NY;
  • Ernst Holler, 12Department of Hematology and Oncology, Internal Medicine III, University Medical Center, Regensburg, Germany; and
  • Michael K. Mansour, 5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA;
  • Marcel R. M. van den Brink, 2Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;3Department of Medicine, Weill Cornell Medical College, New York, NY;
  • Elizabeth Hohmann, 5Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA;
  • Robert R. Jenq, 13Department of Genomic Medicine and14Department of Stem Cell Transplantation Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Yi-Bin Chen, 1Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output